Status:
COMPLETED
Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSD
Lead Sponsor:
Cephalon
Conditions:
Excessive Sleepiness
Shift Work Sleep Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
The primary objective of this study is to determine whether treatment with Armodafinil (CEP-10953) is more effective than placebo treatment for patients with excessive sleepiness associated with chron...
Eligibility Criteria
Inclusion
- Patients are included in the study if all of the following criteria are met:
- Written informed consent is obtained.
- The patient is an outpatient, man or woman of any ethnic origin, 18 to 65 years of age (inclusive).
- The patient has a complaint of excessive sleepiness.
- The patient has a diagnosis of SWSD according to International Classification of Sleep Disorders (ICSD) criteria, and must have had excessive sleepiness during night shifts for at least 3 months.
- The patient must work at least 5 night shifts per month, of which at least 3 nights are consecutive, and plan to maintain this schedule.
- The patient must work night shifts that include at least 6 hours between 2200 and 0800 and be no longer than 12 hours in duration.
- The patient is in good health as determined by a medical and psychiatric history, physical examination, ECG, and serum chemistry and hematology.
- Women must be surgically sterile, 2 years postmenopausal, or, if of child-bearing potential, using a medically accepted method of birth control (ie, barrier method with spermicide, steroidal contraceptive, or intrauterine device \[IUD\]) and agree to continued use of this method for the duration of the study. Steroidal contraceptives must be used with a barrier method while taking the study drug and for at least a full cycle after discontinuation of the study drug.
- The patient has a mean sleep latency of 6 minutes or less as determined by the MSLT
- The patient has a CGI-S rating as it pertains to sleepiness during night shifts including the commute to and from work.
- The patient does not have any medical or psychiatric disorders that could account for the excessive sleepiness during the night shift.
- The patient is able to complete self rating scales and computer-based testing.
- The patient is willing and able to comply with study restrictions and to attend regularly scheduled clinic visits as specified in this protocol.
Exclusion
- Patients are excluded from participating in this study if 1 or more of the following criteria are met:
- has any clinically significant, uncontrolled medical or psychiatric conditions (treated or untreated)
- has a probable diagnosis of a current sleep disorder other than SWSD
- consumes caffeine including coffee, tea and/or other caffeine containing beverages or food averaging more than 600 mg of caffeine per day
- used any prescription drugs disallowed by the protocol or clinically significant use of over the-counter (OTC) drugs within 7 days before the screening/baseline visit
- has a history of alcohol, narcotic, or any other drug abuse as defined by the Diagnostic and Statistical Manual of Mental Disorders of the American Psychiatric Association, 4th Edition (DSM IV)
- has a positive urine drug screen (UDS) at the screening visit
- has a clinically significant deviation from normal in the physical examination
- is a pregnant or lactating woman. (Any woman becoming pregnant during the study will be withdrawn from the study.)
- has used an investigational drug within 1 month before the screening visit
- has any disorder that may interfere with drug absorption, distribution, metabolism, or excretion (including gastrointestinal surgery)
- has a known clinically significant drug sensitivity to stimulants or modafinil
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2004
Estimated Enrollment :
254 Patients enrolled
Trial Details
Trial ID
NCT00080288
Start Date
March 1 2004
End Date
December 1 2004
Last Update
July 19 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.